The lowest values of the limit of the blank (LoB), the limit of detection (LoD), the limit of quantitation (LoQ), and CV < 10% signify hs-cTnI as the most preferred investigation to diagnose AMI within minimal time after the event [1]. The non-AMI conditions in which hs-cTnI have been known to be elevated include increased arterial stiffness, left ventricular hypertrophy (mostly in male subjects), diabetes mellitus, cardiotoxic drugs, and statins [17]. The gene discussed is TNNI3; the disease is left ventricular hypertrophy.